Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Lubitz

Showing results (141-150 of 353) with videos related to

Pageof 36
Sort By:
JAMA Cardiology|May 18, 2022
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National BiobankKiran J Biddinger, Sean J Jurgens, Dimitri Maamari, et al.
Vascular Medicine (London, England)|September 14, 2013
Warfarin pharmacogenetics: a controlled dose-response study in healthy subjectsDaniella L Kadian-Dodov, Sarina A van der Zee, Stuart A Scott, et al.
American Heart Journal|December 17, 2011
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring StudyMichiel Rienstra, Jenny X Sun, Steven A Lubitz, et al.
Journal of Human Genetics|April 18, 2023
Common and rare variants associated with cardiometabolic traits across 98,622 whole-genome sequences in the All of Us research programXin Wang, Justine Ryu, Jihoon Kim, et al.
Circulation|March 2, 2022
Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled TrialSteven A Lubitz, Steven J Atlas, Jeffrey M Ashburner, et al.
Cardiovascular Digital Health Journal|April 27, 2023
Artificial intelligence-enabled classification of hypertrophic heart diseases using electrocardiogramsJulian S Haimovich, Nate Diamant, Shaan Khurshid, et al.
Journal of the American College of Cardiology|March 14, 2020
Titin Truncating Variants in Adults Without Known Congestive Heart FailureJames P Pirruccello, Alexander Bick, Mark Chaffin, et al.
European Heart Journal Open|June 28, 2023
Exploring the link between Gilbert's syndrome and atherosclerotic cardiovascular disease: insights from a subpopulation-based analysis of over one million individualsUri Kartoun, Akl C Fahed, Shinwan Kany, et al.
American Heart Journal|July 22, 2019
Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trialJeffrey M Ashburner, Steven J Atlas, David D McManus, et al.
American Heart Journal|April 26, 2022
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitorDaniel E Singer, Steven J Atlas, Alan S Go, et al.
Pageof 36

Showing results (141-150 of 353) with videos related to

Sort By:
Pageof 36
JAMA Cardiology|May 18, 2022
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National BiobankKiran J Biddinger, Sean J Jurgens, Dimitri Maamari, et al.
Vascular Medicine (London, England)|September 14, 2013
Warfarin pharmacogenetics: a controlled dose-response study in healthy subjectsDaniella L Kadian-Dodov, Sarina A van der Zee, Stuart A Scott, et al.
American Heart Journal|December 17, 2011
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring StudyMichiel Rienstra, Jenny X Sun, Steven A Lubitz, et al.
Journal of Human Genetics|April 18, 2023
Common and rare variants associated with cardiometabolic traits across 98,622 whole-genome sequences in the All of Us research programXin Wang, Justine Ryu, Jihoon Kim, et al.
Circulation|March 2, 2022
Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled TrialSteven A Lubitz, Steven J Atlas, Jeffrey M Ashburner, et al.
Cardiovascular Digital Health Journal|April 27, 2023
Artificial intelligence-enabled classification of hypertrophic heart diseases using electrocardiogramsJulian S Haimovich, Nate Diamant, Shaan Khurshid, et al.
Journal of the American College of Cardiology|March 14, 2020
Titin Truncating Variants in Adults Without Known Congestive Heart FailureJames P Pirruccello, Alexander Bick, Mark Chaffin, et al.
European Heart Journal Open|June 28, 2023
Exploring the link between Gilbert's syndrome and atherosclerotic cardiovascular disease: insights from a subpopulation-based analysis of over one million individualsUri Kartoun, Akl C Fahed, Shinwan Kany, et al.
American Heart Journal|July 22, 2019
Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trialJeffrey M Ashburner, Steven J Atlas, David D McManus, et al.
American Heart Journal|April 26, 2022
ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitorDaniel E Singer, Steven J Atlas, Alan S Go, et al.
Pageof 36